English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 19, 2026

UVA scientists announce new AI tools to speed up drug discovery process
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Study examines why current BET inhibitors fall short in cancer treatment
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Study finds combination therapy may offer safer treatment for Alzheimer’s disease
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Precision medicine tools offer hope for patients with rare blood cancers
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Researchers develop new method to measure global burden of facial pain
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Genetic study links GLP-1 drug response and side effects to inherited variants
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

USC researchers receive NIH grant to model hippocampus changes in Alzheimer’s disease
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Commentary discusses diet and drug combination for neuroblastoma in mice

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes